tiprankstipranks
Advertisement
Advertisement
Cochlear Downgraded to Sell on Structurally Weaker Growth, Demand Risks, and Margin Pressure
PremiumRatingsCochlear Downgraded to Sell on Structurally Weaker Growth, Demand Risks, and Margin Pressure
3M ago
Cochlear Cuts FY26 Profit Guidance as Market Softens but Doubles Down on Growth Investment
Premium
Company Announcements
Cochlear Cuts FY26 Profit Guidance as Market Softens but Doubles Down on Growth Investment
3M ago
Cochlear Reports Lapse and Expiry of Equity Incentive Securities
Premium
Company Announcements
Cochlear Reports Lapse and Expiry of Equity Incentive Securities
4M ago
Cochlear Director Bruce Robinson Increases Indirect Shareholding
PremiumCompany AnnouncementsCochlear Director Bruce Robinson Increases Indirect Shareholding
5M ago
Cochlear’s Next Step: Low-Energy Audio Streaming Trial Signals Steady Innovation for CHEOF
Premium
Company Announcements
Cochlear’s Next Step: Low-Energy Audio Streaming Trial Signals Steady Innovation for CHEOF
5M ago
Cochlear Director Karen Penrose Increases Indirect Shareholding via On-Market Purchase
Premium
Company Announcements
Cochlear Director Karen Penrose Increases Indirect Shareholding via On-Market Purchase
5M ago
Cochlear’s Osia 3 Trial Wraps Up: What the Latest Clinical Update Means for Investors
PremiumCompany AnnouncementsCochlear’s Osia 3 Trial Wraps Up: What the Latest Clinical Update Means for Investors
6M ago
Cochlear’s Nexus App Study Aims to Streamline Implant Fitting and Support Long-Term Growth
Premium
Company Announcements
Cochlear’s Nexus App Study Aims to Streamline Implant Fitting and Support Long-Term Growth
7M ago
Cochlear’s Osia 3 vs Osia 2 Trial Completion: What Investors Should Watch Next
Premium
Company Announcements
Cochlear’s Osia 3 vs Osia 2 Trial Completion: What Investors Should Watch Next
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100